2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action.

@article{Kumar201424Chlorobenzyl6arylimidazo21b134thia,
  title={2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action.},
  author={S. T. Sadish Kumar and Mahesh Hegde and Vidya Gopalakrishnan and Vinaya Kumar Renuka and Sureshbabu A. Ramareddy and Erik de Clercq and Dominique Schols and Anil Kumar Gudibabande Narasimhamurthy and Sathees C. Raghavan and Subhas Somalingappa Karki},
  journal={European journal of medicinal chemistry},
  year={2014},
  volume={84},
  pages={687-97}
}
The cytotoxic activity of a new series of 2-(4'-chlorobenzyl)-5,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazoles against different human and murine cancer cell lines is reported. Among the tested compounds, two derivatives namely 2-(4-chlorobenzyl)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehyde 4i and 2-(4-chlorobenzyl)-6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl thiocyanate 5i emerged as the most potent against all the cell lines. To investigate the… CONTINUE READING